An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for severe illness.
According to The New York Times, that vote came after a near unanimous decision (16 to 2...
FRIDAY, Sept. 17, 2021 (HealthDay News) -- With a special advisory panel to the U.S. Food and Drug Administration meeting Friday to decide on the need for COVID vaccine booster shots, new data shows Pfizer-BioNTech and Moderna vaccines maintaining strong levels of protection against severe illness.
Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday.
The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted because they may contain levels of a nitrosamine, N-nitroso-varenicline, that are at or above levels approved by the U.S. Food and Drug Administration.
In kids and teens, symptoms of long COVID rarely last more than 12 weeks, a new international study reports.
The researchers also found that exposure to the highly contagious Delta variant did not result in more serious disease in children compared to earlier variants, and that most cases of COVID-19 were asymptomatic or mild.
Childhood obesity was a worrisome issue before the pandemic, and now it's alarmingly worse, new data shows.
A U.S. Centers for Disease Control and Prevention study found a "profound increase in weight gain for kids" that is "substantial and alarming," Dr. Alyson Goodman, one of the study's authors, told the Associated Press.
When the COVID-19 public health emergency ends, a new crisis in insurance coverage in the United States may begin.
Fifteen million Americans who enrolled in Medicaid during the pandemic could lose their coverage when the emergency declaration ends, according to an analysis by the Urban Institute, a social policy think tank.
Diseases that can rob you of vision as you age also appear to be tied to an increased risk for dementia, a new study finds.
Specifically, age-related macular degeneration, cataracts and diabetes-related eye disease were linked with a higher likelihood of dementia, researchers in China said. However, one other common eye ailment, glaucoma,...
Steven Reinberg and Ernie Mundell HealthDay Reporters
Cholesterol made in the brain may spur development of Alzheimer's disease, a new study suggests.
Cholesterol made by cells called astrocytes is needed for controlling production of amyloid beta, a sticky protein that builds up in the brain and accumulates into the plaques that are the tell-tale sign of Alzheimer's.
FRIDAY, Sept. 17, 2021 (HealthDay News) – Researchers hoped to show that the natural antioxidant urate could delay Parkinson's disease progression, but a study completed at Massachusetts General Hospital dashed those expectations.
The trial enrolled nearly 300 individuals recently diagnosed with early Parkinson's disease, which affects ...
Movement can be very difficult for people with Parkinson's disease, as shaking and stiffness play havoc with balance, coordination and gait.
There are many different tricks Parkinson's patients can use to improve their walking and avoid injury from a bad tumble -- but a new study reveals that people often have to figure them out on their o...
The "white cane" that many blind people rely on for navigating the world hasn't been upgraded in a century, but researchers are reporting progress on a "robo-cane" they hope will modernize the assistive device.
The prototype cane is equipped with a color 3D camera, sensors and an "on-board" computer designed to guide the user to a desired ...
Health News is provided as a service to Gregg's Pharmacy site users by HealthDay. Gregg's Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.